Neonatal Encephalopathy: Novel Phenotypes and Genotypes Identified by Genome Sequencing.

IF 3.7 3区 医学 Q2 CLINICAL NEUROLOGY Neurology-Genetics Pub Date : 2025-01-13 eCollection Date: 2025-02-01 DOI:10.1212/NXG.0000000000200232
Anastasia Ambrose, Vanda McNiven, Diane Wilson, Aleksandra Tempes, Mary Underwood, Vann Chau, Andreas Schulze, Agnieszka Wyszynska, Karl Desch, Anna R Malik, Saadet Mercimek-Andrews
{"title":"Neonatal Encephalopathy: Novel Phenotypes and Genotypes Identified by Genome Sequencing.","authors":"Anastasia Ambrose, Vanda McNiven, Diane Wilson, Aleksandra Tempes, Mary Underwood, Vann Chau, Andreas Schulze, Agnieszka Wyszynska, Karl Desch, Anna R Malik, Saadet Mercimek-Andrews","doi":"10.1212/NXG.0000000000200232","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Neonatal encephalopathy (NE) is characterized by an abnormal level of consciousness with or without seizures in the neonatal period. It affects 1-6/1,000 live term newborns. We applied genome sequencing (GS) in term newborns with NE to investigate the underlying genetic causes.</p><p><strong>Methods: </strong>We enrolled term newborns according to inclusion/exclusion criteria during their Neonatal Intensive Care admission. We performed GS trio and applied bioinformatic tools. We developed pipelines for manual filters. We applied in silico prediction tools, protein 3D modeling, and functional characterization to assess the pathogenicity of variants.</p><p><strong>Results: </strong>Seventeen newborns fulfilled inclusion criteria. We identified 12 variants in 10 genes. We classified 4 variants in <i>PPP2R5D</i>, <i>BCOR</i>, <i>CFL2</i>, and <i>SCN2A</i> (previously established disease genes) as pathogenic/likely pathogenic; 7 variants in <i>DST</i> (previously established disease gene), <i>STAB2</i>, <i>CELF4</i>, <i>SORCS2</i>, <i>CTNND2</i>, and <i>ASTN1</i> (5 candidate genes) as variants of uncertain significance (VUS); and one variant in <i>STAB2</i> as likely benign. The <i>CELF4</i> and <i>ASTN1</i> copy number variants (CNVs) resulted in structural changes in protein 3D models. The functional characterization of <i>SORCS2</i> VUS revealed disruption of SorCS2 dimer formation and confirmed its pathogenicity. The functional characterization of <i>STAB2</i> variants updated their characterization from VUS/likely benign to benign. The <i>CTNND2</i> VUS resulted in a shift in 3D protein structure. We were not able to perform protein 3D modeling and functional characterization of two <i>DST</i> VUS. We are not certain whether <i>CTNND2</i> and <i>DST</i> variants may be causative of NE in our study.</p><p><strong>Discussion: </strong>The diagnostic rate of research GS was 41% in our prospective study. We broaden the phenotypic spectrum of <i>PPP2R5D</i>-associated Hogue-Janssens syndrome 1, <i>CFL2</i>-associated nemaline myopathy 7, and <i>BCOR</i>-associated oculo-facio-cardio-dental syndrome to include NE and/or neonatal seizures. We identified 3 candidate genes (<i>SORCS2, CELF4, ASTN1</i>) that may cause NE. We believe that protein 3D modeling is an important tool to assess the pathogenicity of CNVs and may advance the discoveries of novel genetic diseases. However, functional characterization of missense variants is essential for discoveries of novel genetic diseases. It seems that GS can help identify more candidate genes compared with ES.</p>","PeriodicalId":48613,"journal":{"name":"Neurology-Genetics","volume":"11 1","pages":"e200232"},"PeriodicalIF":3.7000,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11731368/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology-Genetics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1212/NXG.0000000000200232","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objectives: Neonatal encephalopathy (NE) is characterized by an abnormal level of consciousness with or without seizures in the neonatal period. It affects 1-6/1,000 live term newborns. We applied genome sequencing (GS) in term newborns with NE to investigate the underlying genetic causes.

Methods: We enrolled term newborns according to inclusion/exclusion criteria during their Neonatal Intensive Care admission. We performed GS trio and applied bioinformatic tools. We developed pipelines for manual filters. We applied in silico prediction tools, protein 3D modeling, and functional characterization to assess the pathogenicity of variants.

Results: Seventeen newborns fulfilled inclusion criteria. We identified 12 variants in 10 genes. We classified 4 variants in PPP2R5D, BCOR, CFL2, and SCN2A (previously established disease genes) as pathogenic/likely pathogenic; 7 variants in DST (previously established disease gene), STAB2, CELF4, SORCS2, CTNND2, and ASTN1 (5 candidate genes) as variants of uncertain significance (VUS); and one variant in STAB2 as likely benign. The CELF4 and ASTN1 copy number variants (CNVs) resulted in structural changes in protein 3D models. The functional characterization of SORCS2 VUS revealed disruption of SorCS2 dimer formation and confirmed its pathogenicity. The functional characterization of STAB2 variants updated their characterization from VUS/likely benign to benign. The CTNND2 VUS resulted in a shift in 3D protein structure. We were not able to perform protein 3D modeling and functional characterization of two DST VUS. We are not certain whether CTNND2 and DST variants may be causative of NE in our study.

Discussion: The diagnostic rate of research GS was 41% in our prospective study. We broaden the phenotypic spectrum of PPP2R5D-associated Hogue-Janssens syndrome 1, CFL2-associated nemaline myopathy 7, and BCOR-associated oculo-facio-cardio-dental syndrome to include NE and/or neonatal seizures. We identified 3 candidate genes (SORCS2, CELF4, ASTN1) that may cause NE. We believe that protein 3D modeling is an important tool to assess the pathogenicity of CNVs and may advance the discoveries of novel genetic diseases. However, functional characterization of missense variants is essential for discoveries of novel genetic diseases. It seems that GS can help identify more candidate genes compared with ES.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
新生儿脑病:基因组测序鉴定的新表型和基因型。
背景和目的:新生儿脑病(NE)的特点是意识水平异常,伴有或不伴有新生儿期癫痫发作。它影响1 / 6/ 1000个足月新生儿。我们应用基因组测序(GS)在足月新生儿NE调查潜在的遗传原因。方法:我们在新生儿重症监护住院期间根据纳入/排除标准招募足月新生儿。我们进行了GS三重奏并应用了生物信息学工具。我们开发了手动过滤器的管道。我们应用计算机预测工具、蛋白质3D建模和功能表征来评估变异的致病性。结果:17例新生儿符合纳入标准。我们在10个基因中发现了12个变异。我们将PPP2R5D、BCOR、CFL2和SCN2A(先前确定的疾病基因)中的4个变异分类为致病性/可能致病性;DST(先前确定的疾病基因)、STAB2、CELF4、SORCS2、CTNND2和ASTN1(5个候选基因)中的7个变异为不确定意义变异(VUS);而STAB2的一个变体可能是良性的。CELF4和ASTN1拷贝数变异(CNVs)导致蛋白质3D模型的结构变化。SORCS2 VUS的功能表征揭示了SORCS2二聚体形成的破坏,并证实了其致病性。STAB2变异的功能特征更新了它们的特征,从VUS/可能良性到良性。CTNND2 VUS导致3D蛋白结构的改变。我们无法对两个DST VUS进行蛋白质3D建模和功能表征。在我们的研究中,我们不确定CTNND2和DST变异是否可能是NE的病因。讨论:在前瞻性研究中,研究GS的诊断率为41%。我们扩大了ppp2r5d相关的hogujanssens综合征1、cfl2相关的线状肌病7和bcor相关的眼-面-心-牙综合征的表型谱,将NE和/或新生儿癫痫包括在内。我们确定了3个可能导致NE的候选基因(SORCS2, CELF4, ASTN1)。我们相信,蛋白质3D建模是评估CNVs致病性的重要工具,并可能推动新的遗传疾病的发现。然而,错义变异的功能表征对于发现新的遗传疾病至关重要。与ES相比,GS似乎可以帮助识别更多的候选基因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Neurology-Genetics
Neurology-Genetics Medicine-Neurology (clinical)
CiteScore
6.30
自引率
3.20%
发文量
107
审稿时长
15 weeks
期刊介绍: Neurology: Genetics is an online open access journal publishing peer-reviewed reports in the field of neurogenetics. Original articles in all areas of neurogenetics will be published including rare and common genetic variation, genotype-phenotype correlations, outlier phenotypes as a result of mutations in known disease-genes, and genetic variations with a putative link to diseases. This will include studies reporting on genetic disease risk and pharmacogenomics. In addition, Neurology: Genetics will publish results of gene-based clinical trials (viral, ASO, etc.). Genetically engineered model systems are not a primary focus of Neurology: Genetics, but studies using model systems for treatment trials are welcome, including well-powered studies reporting negative results.
期刊最新文献
Expanding the Genetic Landscape of ATXN2 Variants: Insights From a Biallelic Trinucleotide Repeat Expansion in an Acadian Family. Expanding the Genetic Landscape of Congenital Insensitivity to Pain. Variant Resolution Through RNA Testing and Affected Tissue Analysis in the Neurofibromatoses: A Case Series. Functional Characterization of a De Novo SCN2A Mixed Variant Linked to Early Infantile Developmental and Epileptic Encephalopathy. Pilot Study of Fingolimod Treatment in Neuronal Ceroid Lipofuscinosis Type 1.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1